XCR1 and neoplasm: Among the XCR1 high expression subgroup, only butanoate metabolism, cardiac muscle contraction, Huntington's disease, oxidative phosphorylation, and Parkinson's disease pathways were enriched, among which there is no classical tumor‐associated signaling pathway (Table 5).